Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicamen OrganicsNSE:MEDIORG +4.80%21 Current Ratio is 1.69 as of Mar. 2026, which is 52% above its 10-year median of 1.11. GuruFocus rates NSE:MEDIORG with a GF Score™ of 21/100. The stock has 11 warning signs investors should review. Among 998 Drug Manufacturers companies, Medicamen Organics ranks worse than 59.72% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Medicamen Organics's current ratio for the quarter that ended in Mar. 2026 was 1.69.
Medicamen Organics has a current ratio of 1.69. It generally indicates good short-term financial strength.
The historical rank and industry rank for Medicamen Organics's Current Ratio or its related term are showing as below:
NSE:MEDIORG'
s Current Ratio Range Over the Past 10 Years
Min: 0.86 Med: 1.11 Max: 1.69
Current: 1.69
During the past 6 years, Medicamen Organics's highest Current Ratio was 1.69. The lowest was 0.86. And the median was 1.11.
NSE:MEDIORG's Current Ratio is ranked worse than 59.72% of 998
companies
in the Drug Manufacturers industry
Industry Median: 2
vs NSE:MEDIORG: 1.69
Medicamen Organics (NSE:MEDIORG) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Medicamen Organics Current Ratio Related Terms
Medicamen Organics Current Ratio Historical Data
* Premium members only.
The historical data trend for Medicamen Organics's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MEDIORG vs ZTS, UTHR: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Organics's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicamen Organics Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medicamen Organics's Current Ratio distribution charts can be found below:
* The bar in red indicates where Medicamen Organics's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicamen Organics (NSE:MEDIORG) has a Current Ratio of 1.69 as of Mar. 2026. This is 52% above median its historical median of 1.11. Over the past decade, Medicamen Organics' Current Ratio has ranged from 0.86 to 1.69. According to the industry distribution chart, Medicamen Organics ranks #596 out of 998 companies in the Drug Manufacturers industry, placing it in the top 59.7%.
Is Medicamen Organics' Current Ratio too high?
Medicamen Organics' current Current Ratio of 1.69 is 52% above median its 10-year median of 1.11. Over the past 10 years, this metric has ranged from a low of 0.86 to a high of 1.69. The Drug Manufacturers industry median Current Ratio is 2.00. Medicamen Organics' value of 1.69 is 15.5% below this industry median. Based on the distribution chart, Medicamen Organics ranks #596 out of 998 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Medicamen Organics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Medicamen Organics' Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Medicamen Organics ranks #596 out of 998 companies for Current Ratio. This places Medicamen Organics in the lower half of its industry. The industry median Current Ratio is 2.00. Medicamen Organics' value of 1.69 is 15.5% below this benchmark. Historically, Medicamen Organics' own Current Ratio has ranged from 0.86 to 1.69 over the past decade. While the company's 10-year median is 1.11 vs. the industry median of 2.00, Medicamen Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicamen Organics's current Current Ratio of 1.69 is 15.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicamen Organics's current Current Ratio is 1.69, which is 52% above median its own 10-year median of 1.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Organics stock overvalued right now?
Medicamen Organics (NSE:MEDIORG) has a current Current Ratio of 1.69. The current Current Ratio is 1.69, which is 52% above median its 10-year median of 1.11 and 15.5% below the Drug Manufacturers industry median of 2.00. Medicamen Organics' overall GF Score™ is 21/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Medicamen Organics (NSE:MEDIORG), the current Current Ratio is 1.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
21GF Score
Get the complete analysis for NSE:MEDIORG
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDIORG has been successfully added to your 
